Kaya Ltd H1 FY26: ₹53.8 Cr Sales, ₹18.9 Cr Loss, Promoters Slim Down While Clinics Get a Botox of Capital—The Beauty Chain’s Makeover Looks More Cosmetic Than Core
1. At a Glance
Once upon a time, Kaya Ltd was the glamorous child of Marico, spun off to bottle vanity into a business. Fast forward to H1 FY26, and the mirror’s cracked—sales at ₹53.8 crore and a net loss of ₹18.9 crore, even after divesting its Middle East unit. The stock trades around ₹399, valuing the company at a market cap of ₹606 crore, with zero dividends, negative net worth, and a book value of -₹60.9 per share—a mirror reflection of accumulated beauty bills gone bad.
Debt? ₹278 crore. ROCE? -2.5%. ROE? Also negative, because how do you earn on negative equity? Promoters once held nearly 60%, but post-preferential allotment of ₹75 crore in Aug 2025, their holding dropped to 51.4%, while Axana Estates LLP barged in with 13.76%, becoming the new Botoxed investor in town.
Despite losses, the stock’s done a 15% 1-year return—because the market still loves a redemption story, especially when it involves facials and fund raises.
So yes, Kaya’s still selling confidence, just not on the balance sheet.
2. Introduction
Kaya’s tale could easily be titled “The Curious Case of the Melting Margin.” Once the skincare jewel of Marico’s empire, Kaya demerged to chase glamour independently. Two decades later, it’s still applying foundation over financial scars.
From skin peels to scalp transplants, Kaya has offered “confidence in a clinic” across India and the Middle East, boasting 90+ clinics in 30 cities and 4 countries. But behind the laser machines lies an unflattering truth: a company struggling to turn treatments into profits.
Kaya’s FY25 financials tell a story of shrinking revenues (₹217 crore) and a continuing streak of losses (₹36 crore in FY25 after ₹84 crore profit in FY24 due to one-off income). Its negative working capital and interest coverage ratio of -0.68 scream “beauty is pain.”
And if that wasn’t enough drama, CEO Rajiv Suri quit in Sep 2025, citing “personal reasons.” (Translation: “I’m tired of explaining why beauty costs so much.”)
Still, Kaya’s narrative refuses to fade. The company has pruned its loss-making Middle East business, raised ₹75 crore in new equity, and claims to be “rejuvenating” its Indian operations. But will the turnaround serum finally work—or is this another facial masking a deeper blemish?
3. Business Model – WTF Do They Even Do?
Kaya’s model is simple: make people look good and feel better—then charge them enough to make both parties mildly uncomfortable.
1️ Clinic Services (88% of revenue): Laser hair removal, anti-acne, pigmentation, botox, fillers, and hair transplants—Kaya’s clinics function as beauty hospitals for urban professionals. With 102 dermat machines, it’s less “salon” and more “sci-fi lab.”
2️ Products (12% of revenue): Creams, serums, sunscreens, and nutraceuticals—sold through 130+ retail counters and e-commerce partners like Nykaa, Amazon, Flipkart, and its own website. Basically, the Kaya experience in a bottle—minus the friendly doctor and the bill shock.
3️ Geographical Split:
India (46%) – the core market and focus post-Middle East exit.
Exports (54%) – previously driven by the UAE and KSA clinics, now winding down post divestment.
4️ Asset-Light Ambition: Kaya’s management insists they’re moving toward a “hybrid franchise-clinic model.” Translation: “We need others to pay for our dreams.”
5️ Customer Base: Largely urban women (and a few brave men). Each treatment session can range from ₹3,000 to ₹60,000. But loyalty fades faster than a chemical peel when results aren’t instant.
So in short: Kaya sells vanity, financed by debt, operated through clinics, and narrated through press releases.
4. Financials Overview
Let’s zoom into the latest quarter (Q2 FY26, ended Sept 2025)—the company calls it Half-Yearly Results, so per the lock rule, we stick to that.
Metric (₹ Cr)
H1 FY26
H1 FY25
H2 FY25
YoY %
HoH %
Revenue
53.8
52.5
55.0
2.5%
-2.2%
EBITDA
4.0
6.0
5.0
-33.3%
-20.0%
PAT
-18.9
-10.9
-14.0
-73.4%
-35.0%
EPS (₹)
-12.35
-6.86
-10.76
-80.0%
-14.8%
Commentary: Kaya’s numbers have all the glamour of a Monday morning mirror selfie. Revenue crawled 2.5% YoY, but losses deepened sharply. The operating margin at 3.1% means they earn ₹3 for every ₹100 of service, which is then obliterated by depreciation and interest.
They’re effectively spending ₹105 to earn ₹100—and still smiling for investor selfies.
5. Valuation Discussion – Fair Value Range
Let’s run through some educational number-crunching:
